Literature DB >> 8689814

Thiopurine methyltransferase activity in a Korean population sample of children.

J O Park-Hah1, B Klemetsdal, R Lysaa, K H Choi, J Aarbakke.   

Abstract

Thiopurine methyltransferase (TPMT) is a cytoplasmic enzyme that catalyzes the S-methylation of the cytotoxic drugs 6-mercaptopurine and azathioprine. Red blood cell (RBC) TPMT activity is subject to genetic polymorphism, and we have previously demonstrated an interethnic difference in TPMT activity. To investigate whether there was a race-related difference in RBC TPMT activity, TPMT was measured in a Korean population sample of 309 healthy children. Mean TPMT activity in healthy Korean children was 12.4 +/- 2.4 units/ml RBC, which is similar to the earlier reported TPMT activities in white populations. In contrast to the bimodal or trimodal frequency distributions of RBC TPMT activity in most other population samples, the frequency distribution histogram, the probit plot, and the Shapiro-Wilk test supported a normal distribution of TPMT activity in this Korean population sample of healthy children. Mean RBC TPMT activity showed a tendency to decrease with age, but it was not statistically significant. No gender-related difference in RBC TPMT activity was found.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8689814     DOI: 10.1016/S0009-9236(96)90169-1

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  8 in total

Review 1.  Identifying genomic and developmental causes of adverse drug reactions in children.

Authors:  Mara L Becker; J Steven Leeder
Journal:  Pharmacogenomics       Date:  2010-11       Impact factor: 2.533

2.  Human thiopurine methyltransferase activity varies with red blood cell age.

Authors:  L Lennard; T S Chew; J S Lilleyman
Journal:  Br J Clin Pharmacol       Date:  2001-11       Impact factor: 4.335

3.  Phenotyping and genotyping study of thiopurine S-methyltransferase in healthy Chinese children: a comparison of Han and Yao ethnic groups.

Authors:  Jian-ping Zhang; Yong-yuan Guan; Jue-heng Wu; An-long Xu; Shufeng Zhou; Min Huang
Journal:  Br J Clin Pharmacol       Date:  2004-08       Impact factor: 4.335

4.  Distribution of TPMT risk alleles for thiopurine [correction of thioupurine] toxicity in the Israeli population.

Authors:  Edna Efrati; Lior Adler; Norberto Krivoy; Eli Sprecher
Journal:  Eur J Clin Pharmacol       Date:  2008-12-02       Impact factor: 2.953

5.  Implementation of TPMT testing.

Authors:  Lynne Lennard
Journal:  Br J Clin Pharmacol       Date:  2014-04       Impact factor: 4.335

Review 6.  Thiopurine S-methyltransferase testing for averting drug toxicity: a meta-analysis of diagnostic test accuracy.

Authors:  R M Zur; L M Roy; S Ito; J Beyene; C Carew; W J Ungar
Journal:  Pharmacogenomics J       Date:  2016-05-24       Impact factor: 3.550

7.  Thiopurine methyltransferase activity in Spain: a study of 14,545 patients.

Authors:  Javier P Gisbert; Fernando Gomollón; Carlos Cara; Marta Luna; Yago González-Lama; José María Pajares; José Maté; Luis G Guijarro
Journal:  Dig Dis Sci       Date:  2007-03-02       Impact factor: 3.487

8.  Polymorphisms of the thiopurine S-methyltransferase gene among the Libyan population.

Authors:  Hamza Ben Zeglam; Abdrazak Benhamer; Adel Aboud; Haitem Rtemi; Meftah Mattardi; Saleh Suleiman Saleh; Abdullah Bashein; Nabil Enattah
Journal:  Libyan J Med       Date:  2015-03-26       Impact factor: 1.743

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.